IL320332A - שיטות לטיפול בסרטן - Google Patents

שיטות לטיפול בסרטן

Info

Publication number
IL320332A
IL320332A IL320332A IL32033225A IL320332A IL 320332 A IL320332 A IL 320332A IL 320332 A IL320332 A IL 320332A IL 32033225 A IL32033225 A IL 32033225A IL 320332 A IL320332 A IL 320332A
Authority
IL
Israel
Prior art keywords
methods
treating cancer
cancer
treating
Prior art date
Application number
IL320332A
Other languages
English (en)
Original Assignee
Antares Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antares Therapeutics Inc filed Critical Antares Therapeutics Inc
Publication of IL320332A publication Critical patent/IL320332A/he

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL320332A 2022-10-21 2023-10-20 שיטות לטיפול בסרטן IL320332A (he)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202263418089P 2022-10-21 2022-10-21
US202363443877P 2023-02-07 2023-02-07
US202363469252P 2023-05-26 2023-05-26
PCT/US2023/077441 WO2024086809A1 (en) 2022-10-21 2023-10-20 Methods for treating cancer

Publications (1)

Publication Number Publication Date
IL320332A true IL320332A (he) 2025-06-01

Family

ID=88874777

Family Applications (1)

Application Number Title Priority Date Filing Date
IL320332A IL320332A (he) 2022-10-21 2023-10-20 שיטות לטיפול בסרטן

Country Status (10)

Country Link
EP (1) EP4605392A1 (he)
JP (1) JP2025538097A (he)
KR (1) KR20250110370A (he)
CN (1) CN120418247A (he)
AU (1) AU2023364551A1 (he)
CL (1) CL2025001163A1 (he)
IL (1) IL320332A (he)
MX (1) MX2025004532A (he)
TW (1) TW202421628A (he)
WO (1) WO2024086809A1 (he)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202303419D0 (en) * 2023-03-08 2023-04-19 Otsuka Pharma Co Ltd Compounds
WO2025077778A1 (zh) * 2023-10-12 2025-04-17 上海宇道生物技术有限公司 一类羧酸类化合物及其制备方法和应用
WO2025011684A2 (zh) * 2023-10-20 2025-01-16 上海宇道生物技术有限公司 一类n-磺酰酰胺含氮稠杂环类化合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018055316A1 (fr) * 2016-09-26 2018-03-29 Centre National De La Recherche Scientifique Composes pour leur utilisation en imagerie et notamment pour le diagnostic de maladies neuro-degeneratives
WO2022213975A1 (en) * 2021-04-08 2022-10-13 Jacobio Pharmaceuticals Co., Ltd. Compounds targeting y220c mutant of p53

Also Published As

Publication number Publication date
TW202421628A (zh) 2024-06-01
AU2023364551A1 (en) 2025-05-08
WO2024086809A1 (en) 2024-04-25
CL2025001163A1 (es) 2025-10-03
KR20250110370A (ko) 2025-07-18
MX2025004532A (es) 2025-07-01
CN120418247A (zh) 2025-08-01
EP4605392A1 (en) 2025-08-27
JP2025538097A (ja) 2025-11-26

Similar Documents

Publication Publication Date Title
IL304275A (he) שיטות לטיפול בסרטן
IL312680A (he) שיטות לטיפול בסרטן
IL287907A (he) שיטות לטיפול בסרטן
IL320332A (he) שיטות לטיפול בסרטן
PT4225297T (pt) Terapia de combinação para o tratamento de cancro
ZA202310076B (en) Combination therapies for treating cancer
IL289811A (he) שיטה לטיפול בסרטן
IL319513A (he) תרכובות לטיפול בסרטן
PL4048284T4 (pl) Metoda leczenia nowotworów
AU2024225706A1 (en) Methods for treating breast cancer
CA3262155A1 (en) COMPOUNDS FOR CANCER TREATMENT
CA3254949A1 (en) Polytherapy for the treatment of cancer
IL320471A (he) שיטות לטיפול בסרטן המבטא dll3
IL305974A (he) שילובים רוקחיים לטיפול בסרטן
IL317472A (he) ארבציקלין לטיפול בסרטן
GB202412414D0 (en) Methods for treating cancer
GB201909466D0 (en) Compounds for treating cancer
HK40109687A (en) Methods for treating cancer
GB202300668D0 (en) Cancer treating compounds
HK40095092A (en) Methods for treating cancer
IL317573A (he) טיפול משולב לטיפול בסרטן
IL316016A (he) טיפול משולב לטיפול בסרטן
IL316019A (he) טיפול משולב לטיפול בסרטן
GB201910244D0 (en) Method for treating cancer
CA3252465A1 (en) CANCER TREATMENT